Huadong medicine CO.,Ltd 이메일 인증됨

Established in 1993 and headquartered in Hangzhou, China, Huadong Medicine is among China's top 10 listed pharmaceutical and medical companies, with more than 12,000 employees and revenue of about $5.3 billion in 2021. The company manufactures finished medicines, APIs and aesthetic medicine products, including immunosuppressant, antidiabetic, anti-infection and anti-tumor APIs, ADC toxins, and protected/modified nucleosides/nucleotides for oligonucleotide and mRNA drugs, with main products including mupirocin and tacrolimus.